US studies bolster CryoLife in knee implant case:
This article was originally published in Clinica
US studies released last week by the Centers for Disease Control and Prevention (CDC) and the FDA have served to exonerate Atlanta, Georgia-based CryoLife from any possible involvement in the Minnesota knee implant death. Last month, a small cluster of knee implant deaths aroused concern that a common casual link was to blame. In the event, only one patient had been implanted with a CryoLife product. It transpired, as anticipated by CryoLife, that Clostridium sordellii, a rare bacterial infection, was the cause of the death. CryoLife worked with the agencies to identify the cause. Following the findings, the US agencies have decided that no changes to CryoLife's human tissue processing protocols are necessary.